Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

Enzymatica AB: Invitation to Press Briefing - 5 March 2025

Enzymatica

In connection with the publication of results from two independent research studies on ColdZyme, Enzymatica AB invites to a digital press briefing on 5 March 2025.

  • 13:00-14:10 The researchers will present their findings and be available for questions
  • 14:15-15:00 Enzymatica's CEO, Claus Egstrand, and Chairman, Bengt Baron, will present a company overview and be available for questions

The press briefing will be broadcast live. To participate in the live discussion, please register via this link: https://creo-live.creomediamanager.com/eda7c0f6-7107-4d87-b409-82bdf2d58605

Read the press release published on 28 February here:
https://www.enzymatica.com/media/press-releases/2025/new-independent-studies-show-that-coldzyme-addresses-the-root-cause-of-respiratory-infections-reducing-sick-days-and-symptoms/

Link to the published article in The Journal of Physiology:
https://physoc.onlinelibrary.wiley.com/doi/10.1113/JP288136

 

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.